Back to MW MARSHALL WACE, LLP

LITSLITS
4 quarters

Position history for MWMARSHALL WACE, LLP's holdings in MEI PHARMA INC

Yes. Marshall Wace holds 232,979 shares of LITS (Mei Pharma), worth $214,341, as of its Q2 2026 13F filing. It reduced the position by 100,529 shares (-30.1%) from Q1 2026. Marshall Wace has held LITS since Q3 2025, across 4 quarterly 13F filings.

Current Value

$214,341

Current Shares

232,979

Total Value Change

+$40,202

Total Shares Change

+161,021

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
232,979
-30.1%
$214,3410.0%$0.92
0
2026-Q1
Decreased
333,508
-56.1%
$386,8700.0%$1.16
0
2025-Q4
Increased
759,418
+955.4%
$1M0.0%$1.32
40
2025-Q3
New
71,958
-
$174,1390.0%$2.42
31

Other major holders of LITS: CITADEL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, UBS Group AG

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used